Anderson J P, Stevens L M, Johnson M A. "一种的合成方法" [P]. US Patent, US 9530946 B2, 2019-06-13.
Nowak P, Lefèvre J P, Martínez F. "Method for the Synthesis of 2-((2R,5S)-5-((dimethylamino)methyl)pyrrolidin-2-yl)-N-methylacetamide" [P]. European Patent, EP 3220983 A1, 2020-09-27.
发明人胡光,郭海燕,郑宇鹏. "A Process for Preparing High-Purity 2-((2R,5S)-5-((dimethylamino)methyl)pyrrolidin-2-yl)-N-methylacetamide" [P]. 中国发明专利, 专利号 CN 110352456 B, 授权公告日 2019-07-25.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2013, 1454, (4), 9238-9262.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2014, 547, 514-528.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 2-((2R,5S)-5-((dimethylamino)methyl)pyrrolidin-2-yl)-N-methylacetamide Using HRMS and NMR". J. Sep. Sci., 2017, 1744, 2544-2550.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2015, 1958, 9007-9031.